Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jeffrey Leiden
Biotech
Glick's Odyssey raises $168M to gear up for clinic
Ten months after revealing a $218 million series A, a Gary Glick-helmed biotech is back with another mega round as it prepares for IND-enabling work.
Nick Paul Taylor
Oct 13, 2022 6:30am
Vertex ups CRISPR Therapeutics partnership to $900M upfront
Apr 20, 2021 9:25am
Vertex guns for virtual studies but hits pause on some trials
Mar 27, 2020 8:45am
FDA has dosing questions for Vertex’s Kalydeco follow-up
Apr 27, 2018 9:25am
